tiprankstipranks
Advertisement
Advertisement
Scientific Advisory Board Engagement Underscores Focus on Usher 1B Program at AAVantgarde Bio
PremiumPrivate CompaniesScientific Advisory Board Engagement Underscores Focus on Usher 1B Program at AAVantgarde Bio
18d ago
AAVantgarde Bio to Present Interim LUCE-1 Gene Therapy Data at ARVO 2026
Premium
Private Companies
AAVantgarde Bio to Present Interim LUCE-1 Gene Therapy Data at ARVO 2026
22d ago
AAVantgarde Bio Elevates Profile With Retinal Gene Therapy Showcases and Podcast Exposure
Premium
Private Companies
AAVantgarde Bio Elevates Profile With Retinal Gene Therapy Showcases and Podcast Exposure
22d ago
AAVantgarde Bio Highlights Retinal Gene Therapy Programs at Industry Summit
PremiumPrivate CompaniesAAVantgarde Bio Highlights Retinal Gene Therapy Programs at Industry Summit
25d ago
AAVantgarde Bio Showcases Retinal Gene Therapy Programs at RTIS Summit
Premium
Private Companies
AAVantgarde Bio Showcases Retinal Gene Therapy Programs at RTIS Summit
26d ago
AAVantgarde Bio – Weekly Recap
Premium
Private Companies
AAVantgarde Bio – Weekly Recap
29d ago
AAVantgarde Bio Adds Senior Business Development Leader to Advance Retinal Therapeutics
PremiumPrivate CompaniesAAVantgarde Bio Adds Senior Business Development Leader to Advance Retinal Therapeutics
2M ago
AAVantgarde Bio Highlights Southern Europe’s Growing Biotech Investment Appeal
Premium
Private Companies
AAVantgarde Bio Highlights Southern Europe’s Growing Biotech Investment Appeal
2M ago
AAVantgarde Bio Highlighted as Part of Strengthening Southern Europe Biotech Funding Landscape
Premium
Private Companies
AAVantgarde Bio Highlighted as Part of Strengthening Southern Europe Biotech Funding Landscape
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100